breast cancer

(redirected from BRCA gene)
Also found in: Dictionary, Medical, Encyclopedia.
Related to BRCA gene: BRCA2 gene, Lynch syndrome
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to breast cancer

cancer of the breast

Related Words

References in periodicals archive ?
Olaparib, a poly ADP-ribose polymerase, or PARP, inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced in December.
Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
That test, BRACAnalysis CDx, is made by Myriad Genetics Inc To be a candidate for Lynparza, a patient must take the test and show positive for a specific mutation of the BRCA gene, which confers a high risk of both breast and ovarian cancer.
He spearheaded a campaign against the BRCA gene patents leading to an Australian Senate Inquiry into gene patents.
Such radical measure may only be conducted to women who carry the BRCA gene mutation, following expert's recommendation and genetic counselling.
The guideline does not recommend a specific course of action for women who test positive for BRCA gene mutations.
If anybody in the UAE and region had to check for BRCA gene mutations carrying the risk of cancer, samples had to be collected and sent abroad, which involved delays of weeks if not months.
But the fact that the Court upheld some of Myriad's patents on the BRCA gene sequences has made the situation less simple than it first appeared.
Called the BRCA Babes, the women in the calendar all have the mutated BRCA gene, which leaves them at a higher risk of breast or ovarian cancer.
The genetics section focused on the BRCA gene, which affects one in four Ashkenazi Jew, making it an important issue for Moment to cover.
For 15 years Myriad's patents had given it a monopoly on BRCA gene testing in the United States, limiting the availability of the test and making it impossible for some patients to obtain a second opinion on their results.
Service manager Emma Duncan carries the BRCA gene and was first diagnosed with cancer in her left breast in 2003 and was then diagnosed with cancer in her right breast two years later.
But surgeon Julie Margenthaler, who has studied breast cancer in young women at the Washington University School of Medicine in St Louis, said the new study was limited by a lack of data on women's family history, including which ones were carriers of BRCA gene mutations.
Three different types of claims are at issue: (a) claims involving cDNA of spliced coding regions or isolated DNA of the BRCA1 gene, (b) claims to methods of screening potential cancer therapeutics by analyzing growth rates of cells with altered BRCA genes in the presence or absence of the therapeutics, and (c) claims to methods of analyzing BRCA gene sequences by comparing the cancer-predisposing mutations to normal sequences.